<DOC>
	<DOCNO>NCT00785603</DOCNO>
	<brief_summary>The purpose study examine connection dose paroxetine effect paroxetine tramadols metabolism thereby effect tramadol median pupil size . In study 12 healthy volunteer go 5 phase suppose consume determine dose tramadol 5 various dos paroxetine correspond 5 phase . Fig 1. phase 1 2 3 4 5 Dosis Tramadol mg 50 50 50 50 50 Dosis Paroxetine mg Placebo 10 20 30 50 Paroxetin / placebo 2 ½ placebo 2 placebo 1 ½ placebo 1 placebo tablet ½ paroxetine 1 paroxetine 1 ½ paroxetine 2 ½ paroxetine Fig . 1 summary 5 phase There variation time maximal plasma concentration obtain consumption respectively tramadol ( 1 - 2 hour ) paroxetine ( 6 hour ) . For reason least 6 hour administration paroxetine tramadol . The healthy volunteer brings research medicine home consumes bedtime night day study . At eight o'clock next morning healthy volunteer arrives first pupil measurement consumption tramadol . Tree hour later next pupil measurement carry . The healthy volunteer accumulates urine 2 pm . As paroxetine irreversible inhibitor enzyme CYP2D6 go least 14 day next phase take place . In amount time recreate new pool enzyme .</brief_summary>
	<brief_title>Paroxetines Effect Tramadols Metabolism Pharmakodynamics : Dose Response Study</brief_title>
	<detailed_description>The purpose study examine connection dose paroxetine effect paroxetine tramadols metabolism thereby effect tramadol median pupil size . Tramadol metabolize liver O-desmethyltramadol ( M1 ) catalyse enzyme P450 CYP2D6 N-desmethyltramadol ( M2 ) . Tramadol racemic mixture two enantiomer ( + ) -tramadol hydrochlorid ( - ) -tramadol hydrochlorid therefore form two enantiomer metabolits , ( + ) -M1 ( - ) -M1 . The ( + ) -M1 much high affinity fore human opioid µ-receptor compare ( + ) -tramadol , ( - ) -tramadol ( - ) -M1 . Paroxetine potent inhibitor enzyme CYP2D6 contemporary administration paroxetine tramadol formation active metabolit ( + ) -M1 inhibit . The patient experience poorer analgesic effect tramadol . It also effect ( + ) -M1 opioid µ-receptor result contract pupils show potent paroxetine inhibits enzyme CYP2D6 measure median pupil size . In study 12 healthy volunteer go 5 phase suppose consume determine dose tramadol 5 various dos paroxetine correspond 5 phase . Fig 1. phase 1 2 3 4 5 Dosis Tramadol mg 50 50 50 50 50 Dosis Paroxetine mg Placebo 10 20 30 50 Paroxetin / placebo 2 ½ placebo 2 placebo 1 ½ placebo 1 placebo tablet ½ paroxetine 1 paroxetine 1 ½ paroxetine 2 ½ paroxetine Fig . 1 summary 5 phase There variation time maximal plasma concentration obtain consumption respectively tramadol ( 1 - 2 hour ) paroxetine ( 6 hour ) . For reason least 6 hour administration paroxetine tramadol . The healthy volunteer brings research medicine home consumes bedtime night day study . At eight o'clock next morning healthy volunteer arrives first pupil measurement consumption tramadol . Tree hour later next pupil measurement carry . The healthy volunteer accumulates urine 2 pm . As paroxetine irreversible inhibitor enzyme CYP2D6 go least 14 day next phase take place . In amount time recreate new pool enzyme .</detailed_description>
	<mesh_term>Depression</mesh_term>
	<mesh_term>Paroxetine</mesh_term>
	<mesh_term>Tramadol</mesh_term>
	<criteria>Healthy volunteer judge medical anamnesis examination , inclusive laboratory examination . Signed write approval authorization , witch give relevant people ( GCPunit , Danish Medicines Agency ethic committee Southern Denmark ) access document data interest study Age : 18 45 year Women must use one Danish Medicines Agency define safe contraception . A negative pregnancy test ensure volunteer pregnant start study All volunteer phenotyped CYP2D6 extensive metabolizer ( EM ) `` tramadol test '' : volunteer ingest 50 mg tramadol urine collect fore 8 hour . By HPLC method metabolic ratio ( MR ) ( ) M1/ ( + ) M1 determine urine . Volunteers MRratio small 2 define CYP2D6 EM 's Any clinical significant observation medical laboratory examination Daily use medicine alcohol . Periodic use medicine accept individual valuation doctor Allergy intolerance paroxetine tramadol Former participation clinical study last 3 month</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>February 2009</verification_date>
	<keyword>Depression</keyword>
	<keyword>pain</keyword>
	<keyword>CYP2D6</keyword>
	<keyword>interaction</keyword>
	<keyword>Pupillometry</keyword>
	<keyword>Tramadol</keyword>
	<keyword>Paroxetine</keyword>
	<keyword>MR-ratio</keyword>
</DOC>